Compare WY & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WY | HOLX |
|---|---|---|
| Founded | 1900 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Electronics |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4B | 16.6B |
| IPO Year | 1994 | 1995 |
| Metric | WY | HOLX |
|---|---|---|
| Price | $23.04 | $75.35 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 13 |
| Target Price | $29.00 | ★ $77.89 |
| AVG Volume (30 Days) | ★ 5.4M | 2.2M |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.62% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.45 | ★ 0.79 |
| Revenue | ★ $6,905,000,000.00 | $4,100,500,000.00 |
| Revenue This Year | $6.13 | $4.74 |
| Revenue Next Year | $8.92 | $5.03 |
| P/E Ratio | ★ $51.63 | $95.46 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $21.16 | $51.90 |
| 52 Week High | $30.28 | $75.75 |
| Indicator | WY | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 23.07 | 50.04 |
| Support Level | $22.59 | $75.20 |
| Resistance Level | $24.03 | $75.35 |
| Average True Range (ATR) | 0.59 | 0.19 |
| MACD | -0.21 | -0.02 |
| Stochastic Oscillator | 1.80 | 19.38 |
Weyerhaeuser Co ranks among the world's key forest product companies. Following the 2016 sale of its pulp business to International Paper, Weyerhaeuser operates three business segments: timberlands, wood products, and real estate. Weyerhaeuser is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities. Earnings from its wood products segment are subject to federal income tax. Weyerhaeuser acquired fellow timber REIT Plum Creek in 2016.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.